Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$393K Sell
4,328
-175
-4% -$16K 0.18% 84
2026
Q1
$462K Sell
4,503
-235
-5% -$26.5K 0.24% 72
2025
Q4
$594K Sell
4,738
-60
-1% -$7.64K 0.29% 66
2025
Q3
$643K Sell
4,798
-10
-0.2% -$1.31K 0.31% 65
2025
Q2
$654K Sell
4,808
-3
-0.1% -$396 0.35% 64
2025
Q1
$638K Buy
4,811
+1,314
+38% +$167K 0.38% 63
2024
Q4
$396K Buy
3,497
+75
+2% +$8.67K 0.25% 74
2024
Q3
$390K Sell
3,422
-5
-0.1% -$548 0.26% 76
2024
Q2
$356K Hold
3,427
0.26% 74
2024
Q1
$390K Buy
3,427
+98
+3% +$11.2K 0.3% 69
2023
Q4
$366K Buy
+3,329
New +$333K 0.3% 70

Other funds holding ABT

Wynn Capital's ABT Position: Q2 2026 in Review

Wynn Capital reduced its Abbott (ABT) stake by 3.9% in Q2 2026, selling an estimated $16K and leaving 4,328 shares worth $393K. The position accounts for 0.18% of the portfolio, ranked #84.

Wynn Capital first reported a position in ABT in Q4 2023 and has held it in 11 quarters since. The position peaked at $654K in Q2 2025. 1,369 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

  • Wynn Capital held 4,328 shares of Abbott worth $393K as of Q2 2026.
  • Wynn Capital sold 175 Abbott shares in Q2 2026, an estimated $16K.
  • Abbott made up 0.18% of Wynn Capital's portfolio in Q2 2026, its #84 holding.
  • Wynn Capital first reported a position in Abbott in Q4 2023 and has held it in 11 quarters since.
  • Wynn Capital's Abbott position peaked at $654K in Q2 2025.
  • 1,369 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on Wynn Capital's 13F filing for Q2 2026, filed 8 Jul 2026.